| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/12/2004 | WO2004068140A1 A method for the determination of total antioxidant capacity (tac) and corrected total antioxidant capacity (corrtac) in fluids |
| 08/12/2004 | WO2004068139A2 Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes |
| 08/12/2004 | WO2004068138A1 System and method for measuring coagulation time without thermostatic control |
| 08/12/2004 | WO2004068137A2 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample |
| 08/12/2004 | WO2004068130A2 Method and device for the qualitative and/or quantitative determination of a protein and/or peptide pattern of a fluid sample, which has been taken from the human or animal body |
| 08/12/2004 | WO2004068128A1 Body fluid component analyzing system |
| 08/12/2004 | WO2004068116A2 Receptor deorphanization using tagged molecular libraries |
| 08/12/2004 | WO2004068115A2 Assay method for group transfer reactions |
| 08/12/2004 | WO2004068109A2 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 08/12/2004 | WO2004068105A2 Immunoassay and method of use |
| 08/12/2004 | WO2004068104A2 Target activated microtransfer |
| 08/12/2004 | WO2004067778A2 Differentially expressed genes in large granular lymphocyte leukemia |
| 08/12/2004 | WO2004067774A2 Single nucleotide polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 08/12/2004 | WO2004067770A1 Active dna nanocompartment and its preparation |
| 08/12/2004 | WO2004067742A1 Cleavable assigned molecules and screening method using the same |
| 08/12/2004 | WO2004067741A1 Transcriptional activator |
| 08/12/2004 | WO2004067734A1 Method for determining the influence of a test substance on the heart activity of a vertebrate |
| 08/12/2004 | WO2004067725A2 Methods of identifying modulators of nmur2-mediated activity |
| 08/12/2004 | WO2004067724A2 Methods of identifying and designing cell surface receptor inhibitors |
| 08/12/2004 | WO2004067720A2 Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 08/12/2004 | WO2004067561A1 Amyloid-$g(b)(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 08/12/2004 | WO2004067551A2 Method for identifying peptides by mass spectrometry |
| 08/12/2004 | WO2004067162A2 Apparatus for microfluidic processing and reading of biochip arrays |
| 08/12/2004 | WO2004067131A2 Improved device and method for separation of blood components |
| 08/12/2004 | WO2004067130A2 Method for separating and detecting at least one analyte in biological matrices |
| 08/12/2004 | WO2004067034A1 Use of anti-cd100 antibodies |
| 08/12/2004 | WO2004067026A1 Regulation of allergen induced gene |
| 08/12/2004 | WO2004067023A2 Survivin-derived peptides and use thereof |
| 08/12/2004 | WO2004066948A2 Mapcaxs as modifiers of the apc and axin pathways and methods of use |
| 08/12/2004 | WO2004066946A2 Method for evaluating the efficacy of certain cancer treatments |
| 08/12/2004 | WO2004066943A2 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin |
| 08/12/2004 | WO2004066942A2 Purification and uses of dendritic cells and monocytes |
| 08/12/2004 | WO2004066940A2 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 08/12/2004 | WO2004066937A2 Antibodies specific for plasmacytoid dendritic cells |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004066926A2 Methods and compositions for modulating t lymphocytes |
| 08/12/2004 | WO2004066917A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 08/12/2004 | WO2004066914A2 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | WO2004066808A2 Glycan markers for diagnosing and monitoring disease |
| 08/12/2004 | WO2004066723A1 A model of bone disease amenable to high-throughput screening |
| 08/12/2004 | WO2004057343A3 Detection or determination of variants of factor xiia |
| 08/12/2004 | WO2004057305A3 A milk conveyer device |
| 08/12/2004 | WO2004057294A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 2c (5-ht2c) |
| 08/12/2004 | WO2004056265A3 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 08/12/2004 | WO2004055494A3 Compositions and methods for detecting animal by product in feed |
| 08/12/2004 | WO2004053467A3 Optical sensor for determining the concentrations of dyes and/or particles in liquid or gaseous media and method for operating the same |
| 08/12/2004 | WO2004053144A3 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 08/12/2004 | WO2004053061A8 Methods of therapy and diagnosis using targeting of cells that express lax |
| 08/12/2004 | WO2004050912A3 Method and kit for ribonucleoside-specific detection and quantification |
| 08/12/2004 | WO2004050901A3 Method for the selection of cells producing specifically binding molecules |
| 08/12/2004 | WO2004048613A3 Dual assay for evaluating activity and cytotoxicity of compounds in the same |
| 08/12/2004 | WO2004047615A3 Hemiasterlin affinity probes and their uses |
| 08/12/2004 | WO2004046377A3 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 08/12/2004 | WO2004045559A3 Method for the prevention of malaria |
| 08/12/2004 | WO2004045556A3 Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens |
| 08/12/2004 | WO2004045545A3 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 08/12/2004 | WO2004044581A3 Transcriptional regulation of crlr and uses thereof |
| 08/12/2004 | WO2004044558A3 A method and apparatus for determining a property of a sample |
| 08/12/2004 | WO2004044547A3 Oxygen monitoring device |
| 08/12/2004 | WO2004043563A3 Methods of isolation of active compounds and activated targets |
| 08/12/2004 | WO2004042380A3 Gas sensor |
| 08/12/2004 | WO2004042356A3 Apparatus and method to calibrate a gas detector |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004034056A3 Portable diagnostic device and method for determining temporal variations in concentrations |
| 08/12/2004 | WO2004029625A3 Detecting molecular binding by monitoring feedback controlled cantilever deflections |
| 08/12/2004 | WO2004025257A3 Methods and systems for estimating the melting temperature (tm) for polynucleotide molecules |
| 08/12/2004 | WO2004020976A3 Diagnostic assay for thrombin-activatable fibrinolysis inhibitor (tafi) |
| 08/12/2004 | WO2004016802A3 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 08/12/2004 | WO2004016171A8 Device and method for in vitro determination of analyte concentrations within body fluids |
| 08/12/2004 | WO2004015133A3 Combinatorial synthesis system |
| 08/12/2004 | WO2004015131A3 Hepatitis c virus assays |
| 08/12/2004 | WO2004015071A3 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 08/12/2004 | WO2004011594A3 Novel method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 08/12/2004 | WO2004009733A3 Asphaltene aggregation in petroleum oil mixtures determined by small angle light scattering |
| 08/12/2004 | WO2004007531A3 Activated checkpoint therapy and methods of use thereof |
| 08/12/2004 | WO2004005893A3 Apparatus for metering analytes contained in a liquid sample and related process |
| 08/12/2004 | WO2004003561A9 Peptide rod amphiphiles and self-assembly of same |
| 08/12/2004 | WO2004003512A3 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 08/12/2004 | WO2004003132A3 Methods and systems of biomolecular sequence matching |
| 08/12/2004 | WO2004001372A3 Fabrication of high resolution biological molecule detection device |
| 08/12/2004 | WO2003085372A3 Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| 08/12/2004 | WO2003084388A3 Early detection of sepsis |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003071927A3 Diagnostics and therapeutics for macular degeneration-related disorders |
| 08/12/2004 | WO2003066802A3 Gene expression analysis using nicking agents |
| 08/12/2004 | WO2003051182A3 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 08/12/2004 | WO2003048337A3 Antibody to latent membrane proteins and uses thereof |
| 08/12/2004 | WO2003039484A3 Novel compositions and methods for cancer |
| 08/12/2004 | WO2003039441A3 Unc-13 in the modulation of neurotransmission and secretion events |
| 08/12/2004 | WO2003026573A3 Screening and selection methods for statin drug combinations |
| 08/12/2004 | WO2003023357A3 Compounds and methods for fluorescent labeling |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002086147A3 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 08/12/2004 | WO2002059299A9 Expression cloning method |
| 08/12/2004 | WO2002059144A9 Differential labeling for quantitative analysis of complex protein mixtures |
| 08/12/2004 | WO2002040997A3 Production and use of proteins producing an altered immunogenic response |
| 08/12/2004 | WO2001068807A3 Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme |
| 08/12/2004 | US20040158411 Device for determining thermophysical properties of a multi-component gas at arbitrary temperature and pressure |
| 08/12/2004 | US20040158410 Carbon dioxide sensor |